menu
    • menu

    Company profile for Fresenius Medical Care

    NEW Drugs in Dev: 4
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases. We aim to create a future worth living for chronically and critically ill patients – worldwide and every day. Thanks to our decades of experience in dialysis, our innovative research and our value-based care approach, we can help them to enjoy the very best quality of life. Our portfolio encompasses a ...
    Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases. We aim to create a future worth living for chronically and critically ill patients – worldwide and every day. Thanks to our decades of experience in dialysis, our innovative research and our value-based care approach, we can help them to enjoy the very best quality of life. Our portfolio encompasses a comprehensive range of high-quality health care products and services as well as various dialysis treatment options for both in-center and home dialysis that are individually tailored to our patients’ needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Fresenius Medical CareMexico Flag
    Country
    Country
    Mexico
    Address
    Address
    Torre Mural, Insurgentes Sur 1605 Floor 29, Col. San José Insurgentes. CP 039...
    Telephone
    Telephone
    (01) 55 4170 4005 / 4010
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.freseniusmedicalcare.com/en/home
    Linkedin
    Linkedin
    https://www.linkedin.com/company/freseniusmedicalcare/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Humacyte Realigns Non-U.S. Symvess Rights for Expansion
    Humacyte Realigns Non-U.S. Symvess Rights for Expansion

    24 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/24/3280751/0/en/humacyte-expands-commercial-and-business-development-opportunities-through-realignment-of-ex-u-s-rights-to-symvess.html

    GLOBENEWSWIRE
    24 Apr 2026
    Share Share
    Cancer Drug Makers Seek 50% Price Hike Amid Platinum Surge
    Cancer Drug Makers Seek 50% Price Hike Amid Platinum Surge

    06 Apr 2026

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cancer-drug-makers-seek-50-price-hike-as-platinum-surge-hits-production-viability/articleshow/130046021.cms

    ECONOMICTIMES
    06 Apr 2026
    Share Share
    Quest Diagnostics Acquires Spectra Labs' Clinical Testing Assets
    Quest Diagnostics Acquires Spectra Labs' Clinical Testing Assets

    08 Aug 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/diagnostic-center/quest-diagnostics-completes-acquisition-of-spectra-laboratories-clinical-testing-assets-from-fresenius-medical-care-17559

    INDPHARMAPOST
    08 Aug 2025
    Share Share
    Fresenius' Frenova Advances Genomics-Driven Kidney Disease Care
    Fresenius' Frenova Advances Genomics-Driven Kidney Disease Care

    31 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fresenius-medical-cares-third-party-clinical-research-organization-frenova-announces-strategic-collaboration-advancing-genomics-driven-precision-kidney-disease-care-302518644.html

    PR NEWSWIRE
    31 Jul 2025
    Share Share
    Fresenius to boost output after hurricane damage at rival Baxter
    Fresenius to boost output after hurricane damage at rival Baxter

    08 Oct 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/fresenius-looking-boost-production-after-hurricane-damage-baxter-2024-10-08/

    REUTERS
    08 Oct 2024
    Share Share
    Fresenius beats Q2 view on strong unit performance, cost savings
    Fresenius beats Q2 view on strong unit performance, cost savings

    30 Jul 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/fresenius-beats-q2-expectations-strong-unit-performance-cost-savings-2024-07-31/

    REUTERS
    30 Jul 2024
    Share Share

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    SAfety of Regional Citrate Anticoagulation (SARCA Study)

    Details:

    Dialysis is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Acute Kidney Injury.


    Lead Product(s): Dialysis

    Therapeutic Area: Nephrology Brand Name: Undisclosed

    Study Phase: Phase IIIProduct Type: Undisclosed

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable April 21, 2022

    blank

    01

    Fresenius Medical Care

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed

    Fresenius Medical Care

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Dialysis

    Therapeutic Area : Nephrology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    SAfety of Regional Citrate Anticoagulation (SARCA Study)

    Details : Dialysis is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Acute Kidney Injury.

    Product Name : Undisclosed

    Product Type : Undisclosed

    Upfront Cash : Inapplicable

    April 21, 2022

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules

    Details:

    Calcium Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Hyperphosphatemia.


    Lead Product(s): Calcium Acetate,Magnesium Carbonate

    Therapeutic Area: Nephrology Brand Name: Undisclosed

    Study Phase: Phase II/ Phase IIIProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable January 06, 2014

    blank

    02

    Fresenius Medical Care

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed

    Fresenius Medical Care

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Calcium Acetate,Magnesium Carbonate

    Therapeutic Area : Nephrology

    Highest Development Status : Phase II/ Phase III

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules

    Details : Calcium Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Hyperphosphatemia.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    January 06, 2014

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    The Effect of Balance PD Solution on the Peritoneal Membrane in Patients on Automated Peritoneal Dialysis

    Details:

    Glucose is a Dietary Supplement drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Kidney Failure, Chronic.


    Lead Product(s): Glucose

    Therapeutic Area: Nephrology Brand Name: Undisclosed

    Study Phase: Phase IVProduct Type: Dietary Supplement

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable December 20, 2012

    blank

    03

    Fresenius Medical Care

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed

    Fresenius Medical Care

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Glucose

    Therapeutic Area : Nephrology

    Highest Development Status : Phase IV

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    The Effect of Balance PD Solution on the Peritoneal Membrane in Patients on Automated Peritoneal D...

    Details : Glucose is a Dietary Supplement drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Kidney Failure, Chronic.

    Product Name : Undisclosed

    Product Type : Dietary Supplement

    Upfront Cash : Inapplicable

    December 20, 2012

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients

    Details:

    Sucroferric Oxyhydroxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Renal Insufficiency, Chronic.


    Lead Product(s): Iron Sucrose

    Therapeutic Area: Nephrology Brand Name: Undisclosed

    Study Phase: Phase IIIProduct Type: Miscellaneous

    Recipient: CSL Vifor

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable November 03, 2011

    blank

    04

    Fresenius Medical Care

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed

    Fresenius Medical Care

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Iron Sucrose

    Therapeutic Area : Nephrology

    Highest Development Status : Phase III

    Recipient : CSL Vifor

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, ...

    Details : Sucroferric Oxyhydroxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Renal Insufficiency, Chronic.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    November 03, 2011

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients

    Details:

    Calcium Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Renal Insufficiency, Chronic.


    Lead Product(s): Calcium Acetate

    Therapeutic Area: Nephrology Brand Name: Undisclosed

    Study Phase: Phase IVProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable September 02, 2011

    blank

    05

    Fresenius Medical Care

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed

    Fresenius Medical Care

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Calcium Acetate

    Therapeutic Area : Nephrology

    Highest Development Status : Phase IV

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patie...

    Details : Calcium Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Renal Insufficiency, Chronic.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    September 02, 2011

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients

    Details:

    Sucroferric Oxyhydroxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Renal Insufficiency, Chronic.


    Lead Product(s): Iron Sucrose

    Therapeutic Area: Nephrology Brand Name: Undisclosed

    Study Phase: Phase IIIProduct Type: Miscellaneous

    Recipient: CSL Vifor

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable March 28, 2011

    blank

    06

    Fresenius Medical Care

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed

    Fresenius Medical Care

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Iron Sucrose

    Therapeutic Area : Nephrology

    Highest Development Status : Phase III

    Recipient : CSL Vifor

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Pa...

    Details : Sucroferric Oxyhydroxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Renal Insufficiency, Chronic.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    March 28, 2011

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    A Safety Study of Pentoxifylline for the Treatment of Anemia

    Details:

    Erythropoietin is a Protein drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Kidney Failure, Chronic.


    Lead Product(s): ERYTHROPOIETIN,Pentoxifylline

    Therapeutic Area: Nephrology Brand Name: Undisclosed

    Study Phase: Phase IIProduct Type: Protein

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable April 13, 2010

    blank

    07

    Fresenius Medical Care

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed

    Fresenius Medical Care

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : ERYTHROPOIETIN,Pentoxifylline

    Therapeutic Area : Nephrology

    Highest Development Status : Phase II

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    A Safety Study of Pentoxifylline for the Treatment of Anemia

    Details : Erythropoietin is a Protein drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Kidney Failure, Chronic.

    Product Name : Undisclosed

    Product Type : Protein

    Upfront Cash : Inapplicable

    April 13, 2010

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDA Orange Book

    read-more
    read-more

    Europe

    read-more
    read-more

    01

    Brand Name : Capd/Dpca

    Mexico
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : Capd/Dpca

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Authorized

    Registration Country : Spain

    Anhydrous Glucose; Sodium Chloride; Sodium Lactate; Calcium Chloride Dihydrate; Magnesium Chloride Hexahydrate

    Fresenius Medical Care

    Dosage Form : Solution For Peritoneal Dialys...

    Dosage Strength :

    Packaging :

    Brand Name : Capd/Dpca

    Approval Date : 01-04-1998

    Application Number : 61887

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : Capd/Dpca

    Mexico
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : Capd/Dpca

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Authorized

    Registration Country : Spain

    Anhydrous Glucose; Sodium Chloride; Sodium Lactate; Calcium Chloride Dihydrate; Magnesium Chloride Hexahydrate

    Fresenius Medical Care

    Dosage Form : Solution For Peritoneal Dialys...

    Dosage Strength :

    Packaging :

    Brand Name : Capd/Dpca

    Approval Date : 01-04-1998

    Application Number : 61886

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : Capd/Dpca

    Mexico
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : Capd/Dpca

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Authorized

    Registration Country : Spain

    Anhydrous Glucose; Sodium Chloride; Sodium Lactate; Calcium Chloride Dihydrate; Magnesium Chloride Hexahydrate

    Fresenius Medical Care

    Dosage Form : Solution For Peritoneal Dialys...

    Dosage Strength :

    Packaging :

    Brand Name : Capd/Dpca

    Approval Date : 01-04-1998

    Application Number : 61888

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : Tavneos

    Mexico
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : Tavneos

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Prescription

    Registration Country : Denmark

    Avacopan

    Fresenius Medical Care

    Dosage Form : Hard Capsules

    Dosage Strength : 10mg

    Packaging :

    Brand Name : Tavneos

    Approval Date : 11-01-2022

    Application Number : 28106520020

    Regulatory Info : Prescription

    Registration Country : Denmark

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : Rayaldee

    Mexico
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : Rayaldee

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Prescription

    Registration Country : Denmark

    Calcifediol

    Fresenius Medical Care

    Dosage Form : Prolonged-Release Capsules

    Dosage Strength : 30mcg

    Packaging :

    Brand Name : Rayaldee

    Approval Date : 10-09-2020

    Application Number : 28106256419

    Regulatory Info : Prescription

    Registration Country : Denmark

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : Calrecia

    Mexico
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : Calrecia

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Authorized

    Registration Country : Spain

    Calcium Chloride Dihydrate

    Fresenius Medical Care

    Dosage Form : Solution For Perfusion

    Dosage Strength : 100MMOL

    Packaging :

    Brand Name : Calrecia

    Approval Date : 01-03-2019

    Application Number : 83899

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : Sorbisterit Powder F...

    Mexico
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : Sorbisterit Powder F...

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Authorized

    Registration Country : Spain

    Calcium Polystyrene Sulfonate

    Fresenius Medical Care

    Dosage Form : Rectal/Oral Solution

    Dosage Strength :

    Packaging :

    Brand Name : Sorbisterit Powder For Oral/R...

    Approval Date : 04-09-2007

    Application Number : 69234

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : Kapruvia

    Mexico
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : Kapruvia

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Prescription

    Registration Country : Denmark

    Dipheline Acetate

    Fresenius Medical Care

    Dosage Form : Injection Solution

    Dosage Strength : 50mcg/ml

    Packaging :

    Brand Name : Kapruvia

    Approval Date : 25-04-2022

    Application Number : 28106589821

    Regulatory Info : Prescription

    Registration Country : Denmark

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : Capd/Dpca 19

    Mexico
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : Capd/Dpca 19

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Authorized

    Registration Country : Spain

    Glucose Monohydrate; Anhydrous Glucose; Sodium Chloride; Sodium Lactate; Calcium Chloride Dihydrate; Magnesium Chloride Hexahydrate

    Fresenius Medical Care

    Dosage Form : Solution For Peritoneal Dialys...

    Dosage Strength :

    Packaging :

    Brand Name : Capd/Dpca 19

    Approval Date : 14-07-2000

    Application Number : 63235

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : Multibic

    Mexico
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : Multibic

    Mexico
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Authorized

    Registration Country : Spain

    Glucose Monohydrate; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride; Calcium Chloride; Magnesium Chloride Hexahydrate

    Fresenius Medical Care

    Dosage Form : Potassium Solution For Hemofil...

    Dosage Strength : 2MMOL

    Packaging :

    Brand Name : Multibic

    Approval Date : 11-12-2003

    Application Number : 65804

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search